Tootfinder

"So, I climbed to the top of the pyramid of pain - now what?"
An interesting Human Layer Kill Chain framework.
#threatintel #threatintelligence
🔗

Trump threatens Musk the same way he did Harvard (Steve Inskeep/Differ We Must)
https://steveinskeep.substack.com/p/trump-threatens-musk-the-same-way
http://www.memeorandum.com/250605/p146#a250605p146

‘Step Out Now!’: Florida Cop Suspended After Threatening to Kick Down Door Before Yanking Out Autistic Man Over Fabricated Jaywalking Allegation
https://atlantablackstar.com/2025/06/06/florida-cop-suspended-after-threatening-to-kick-down-door-before-yanking-out-autistic-man-over-fabricated-jaywalking-allegation/

Bills' Frank Gore Jr. gets ridiculed by teammates for 'FGJ' autograph that appeared on trading card

https://www.cbssports.com/nfl/news/bills-f…

Palantir removed three journalists from a security conference after they asked about its work with ICE and threatened to call police on a Wired reporter (Caroline Haskins/Wired)
https://www.wired.com/story/palantir-defense-conference-journalists/

Palantir Is Going on Defense
Palantir threatened to call police on a WIRED reporter and kicked out other journalists from a recent conference following reports of the data analytics firm’s work with the Trump administration.

Two-Phase Treatment with Noncompliance: Identifying the Cumulative Average Treatment Effect via Multisite Instrumental Variables
Guanglei Hong, Xu Qin, Zhengyan Xu, Fan Yang
https://arxiv.org/abs/2506.03104

Two-Phase Treatment with Noncompliance: Identifying the Cumulative Average Treatment Effect via Multisite Instrumental Variables
In evaluating a multi-phase intervention, the cumulative average treatment effect (ATE) is often the causal estimand of key interest. Yet some individuals who do not respond well to the Phase-I treatment may subsequently display noncompliant behaviors. However, noncompliance tends to be constrained by the stochastic availability of slots under the alternative treatment condition in Phase II, which makes the notion of the "complier average treatment effect" problematic. Moreover, the Phase-I tre…

What Makes Treatment Effects Identifiable? Characterizations and Estimators Beyond Unconfoundedness
Yang Cai, Alkis Kalavasis, Katerina Mamali, Anay Mehrotra, Manolis Zampetakis
https://arxiv.org/abs/2506.04194

What Makes Treatment Effects Identifiable? Characterizations and Estimators Beyond Unconfoundedness
Most of the widely used estimators of the average treatment effect (ATE) in causal inference rely on the assumptions of unconfoundedness and overlap. Unconfoundedness requires that the observed covariates account for all correlations between the outcome and treatment. Overlap requires the existence of randomness in treatment decisions for all individuals. Nevertheless, many types of studies frequently violate unconfoundedness or overlap, for instance, observational studies with deterministic tr…

I wrote a newsletter for over a year where shared strong and weak industries based on the stock market performance. In it I also discussed my personal trading. Well, on February 16th I made a special post where I announced that the market has completely changed and with it, my trading approach is changing too:
ht…

Stock Sector Scout, 16 February 2025
A note on market evolution and changes to Stock Sector Scout: Adapting my approach for current conditions

Kennedy Says 'Charlatans' Are No Reason to Block Unproven Stem Cell Treatments (Christina Jewett/New York Times)
https://www.nytimes.com/2025/06/05/health/kennedy-stem-cells-experimental-treatments.html
http://www.memeorandum.com/250605/p147#a250605p147

Trump and His Team Tease Vengeance Against Elon as Feud Goes Nuclear (Rolling Stone)
https://www.rollingstone.com/politics/politics-features/trump-threatens-vengeance-against-elon-musk-feud-1235356996/
http://www.memeorandum.com/250605/p123#a250605p123